e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical issues in granulomatous lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Correlation of King’s Sarcoidosis Questionnaire with clinical parameters
B. Frye (Freiburg, Germany), E. Farin-Glattacker (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany), J. Schupp (New Haven, United States of America)
Source:
Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Session:
Clinical issues in granulomatous lung diseases
Session type:
E-poster session
Number:
3016
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Frye (Freiburg, Germany), E. Farin-Glattacker (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany), J. Schupp (New Haven, United States of America). Correlation of King’s Sarcoidosis Questionnaire with clinical parameters. 3016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Pulmonary sarcoidosis
Related content which might interest you:
Translation and initial validation of King’s Sarcoidosis Questionnaire
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Health Related Quality of Life (HRQL) in sarcoidosis – Sarcoidosis Health Questionnaire (SHQ) and correlation with clinical course of sarcoidosis – follow up study
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006
A comparison of two scoring methods for the King’s sarcoidosis questionnaire
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference
Source: Eur Respir J, 54 (3) 1900281; 10.1183/13993003.00281-2019
Year: 2019
Assessing the Liverpool Respiratory Symptom Questionnaire in children with cystic fibrosis
Source: Eur Respir J 2012; 39: 899-905
Year: 2012
Prevalence of Anxiety Disorders and Depression in Patients with Chronic Obstructive Pulmonary Disease and correlation with the clinical stage of the disease
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Assessing sarcoidosis: The King‘s Sarcoidosis Questionnaire and the minimal important difference
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012
Validity and reliability of the Stanford Brief Activity Survey (SBAS) in patients with COPD
Source: Annual Congress 2010 - Outcomes in chronic lung disease: assessing the value of interventions – physical activity, strength and exercise
Year: 2010
King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD)
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Validation of the King’s Brief Interstitial Lung Disease questionnaire in Danish
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
The Profile of Sarcoidosis in Greece: Clinical characteristics, Extra-pulmonary manifestations, Long-term Follow-up
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Psychometric validation of the Korean PROMIS-29 Profile v2.1 among patients with chronic pulmonary diseases in Korea
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021
Translation and validation of the Quality-of-Life Bronchiectasis questionnaire in Swedish, and correlation with clinical outcomes.
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Comparative Evaluation of Clinical, Spiro/Oscillometric and Tomographic Parameters As A Global Assessment of Children With Cystic Fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Reliability & validity testing of the Seattle Pulmonary Exacerbation score in paediatric patients with CF
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) validated to Portuguese respiratory patients
Source: International Congress 2019 – Insights into assessment of functional status in respiratory disease patients
Year: 2019
Development of pediatric cross-cultural patient-reported outcome measures: QOL-PCD
Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis
Year: 2014
Health-related quality of life in COPD: why both disease-specific and generic measures should be used
Source: Eur Respir J 2001; 18: 69-76
Year: 2001
Clinical and laboratory parameters to categorise Sarcoidosis
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept